Richard U De Schutter
CIK 1083205 · last filed 2024-04-02
Richard U De Schutter is a corporate insider who has filed 90 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $26.9K of BLCO on Apr 2, 2024. Across all open-market trades the lifetime net is −$7.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.6M across reported positions. 44 SEC filings were submitted jointly with Bausch Health Companies Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INCY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLCO | Director | 32,952 | $17.36 | $572.2K | $0 | 7 | 2024-04-02 |
| BHC | Director | 387,207 | $6.33 | $2.45M | $3.43M | 26 | 2023-04-04 |
| INCY | Director | 92,290 | $115.90 | $10.70M | -$10.78M | 15 | 2015-03-09 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | — | — | — | $0 | 1 | 2013-05-20 |
| ECL | Director | 9,900 | $289.41 | $2.87M | $104.5K | 19 | 2010-04-20 |
Recent Filings
90 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-02 | BLCO | Grant (A) | +1,553 | $26.9K | EDGAR |
| 2024-01-03 | BLCO | Grant (A) | +1,575 | $26.9K | EDGAR |
| 2023-10-03 | BLCO | Grant (A) | +1,585 | $26.9K | EDGAR |
| 2023-07-05 | BLCO | Grant (A) | +1,339 | $26.9K | EDGAR |
| 2023-05-05 | BLCO | Grant (A) | +12,857 | $0 | EDGAR |
| 2023-04-04 | BLCO | Grant (A) | +1,543 | $26.9K | EDGAR |
| 2023-04-04 | BHC | Grant (A) | +3,642 | $29.5K | EDGAR |
| 2023-01-03 | BHC | Grant (A) | +5,186 | $32.6K | EDGAR |
| 2022-10-03 | BHC | Grant (A) | +4,989 | $34.4K | EDGAR |
| 2022-07-05 | BHC | Grant (A) | +4,111 | $34.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.